Parums Dinah V
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA.
Med Sci Monit. 2025 Aug 27;31:e951118. doi: 10.12659/MSM.951118.
Real-world data are routinely collected data associated with patient health status or delivery of health care from sources including patient registries, electronic health records (EHRs), medical claims data, or digital health technologies. Real-world evidence is generated from specified clinical real-world data and includes evidence of the use, benefits, and risks of a medical product. Analysis of real-world data is the basis of real-world evidence to support the use and potential benefits or risks of a medical product. Also, real-world insights are generated when real-world evidence is interpreted or applied by different stakeholders in the healthcare industry to inform the planning of clinical research studies, identifying research questions, relevant patient or disease groups, disease trends over time, and evaluating the commercial viability of a study, which can improve healthcare planning and implementation. The importance of standardizing and regulating the conduct and reporting of real-world studies is highlighted by the increasing number of registered studies. This article aims to review the continued importance and relevance of real-world evidence from real-world studies and data to support and refine interpretations from controlled clinical trials.
真实世界数据是从包括患者登记系统、电子健康记录(EHR)、医疗理赔数据或数字健康技术等来源常规收集的与患者健康状况或医疗保健提供相关的数据。真实世界证据源自特定的临床真实世界数据,包括医疗产品的使用、益处和风险的证据。对真实世界数据的分析是支持医疗产品使用及其潜在益处或风险的真实世界证据的基础。此外,当医疗行业的不同利益相关者对真实世界证据进行解读或应用,以指导临床研究规划、确定研究问题、相关患者或疾病群体、随时间变化的疾病趋势以及评估研究的商业可行性时,就会产生真实世界见解,这有助于改善医疗保健规划与实施。越来越多的注册研究凸显了规范真实世界研究的开展和报告的重要性。本文旨在回顾真实世界研究和数据中真实世界证据持续存在的重要性及相关性,以支持和完善来自对照临床试验的解读。